<Record>
<Term>Autologous Dendritic Cell-Allogeneic Melanoma Tumor Cell Lysate Vaccine</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Dendritic Cell Vaccine</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Biological Response Modifier/Vaccine/Antineoplastic Vaccine/APC Vaccine/Dendritic Cell Vaccine/Autologous Dendritic Cell-Allogeneic Melanoma Tumor Cell Lysate Vaccine</ClassificationPath>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>APC Vaccine</BroaderTerm>
<BroaderTerm>Antineoplastic Vaccine</BroaderTerm>
<BroaderTerm>Autologous Dendritic Cell-Allogeneic Melanoma Tumor Cell Lysate Vaccine</BroaderTerm>
<BroaderTerm>Dendritic Cell Vaccine</BroaderTerm>
<BroaderTerm>Biological Response Modifier</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<BroaderTerm>Vaccine</BroaderTerm>
<Synonym>Allogeneic Melanoma Cell-Loaded Dendritic Cell Vaccine</Synonym>
<Synonym>Autologous Dendritic Cell-Allogeneic Melanoma Tumor Cell Lysate Vaccine</Synonym>
<Synonym>IDD-3</Synonym>
<Description>A cell-based vaccine composed of autologous dendritic cells (DCs) pulsed with lysates from heat-treated allogeneic melanoma tumor cells. Upon administration, this vaccine may stimulate anti-tumoral cytotoxic T-cell and antibody responses to melanoma cells bearing shared melanoma antigens such as MelanA/MART-1, gp100, MAGE3, resulting in tumor cell lysis.</Description>
<Source>NCI Thesaurus</Source>
</Record>
